KYG7487R1002
KYG7487R1002
Regencell Bioscience Holdings L
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2024 | 2023 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 4.736.726 | 6.273.671 | 24.5% | |
| Operating Income | -4.736.726 | -6.273.671 | 24.5% |
| Pretax Income | -4.363.221 | -6.062.329 | 28.0% |
| Net Income Common Stockholders | -4.301.837 | -5.871.130 | 26.7% |
| -- | -- | -- | |
| -- | -- | -- |